-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, Guangzhou Pharmaceutical Group held the completion and commissioning ceremony of the Guangzhou Pharmaceutical International Pharmaceutical Factory in Macau and the unveiling ceremony of the Guangzhou Pharmaceutical-University of Australia Co-construction of the Chinese Medicine Industry Transformation Joint Laboratory in Macau.
New progress has been made in the cooperation between Guangdong and Macao in Chinese medicine
.
Guangzhou Pharmaceutical International Macau Pharmaceutical Factory is currently the largest and the first Chinese patent medicine pharmaceutical factory designed and constructed in accordance with modern GMP standards in Macau.
Guangyao-University of Australia jointly established a joint laboratory for the transformation of Chinese medicine industry relying on the State Key Laboratory of Traditional Chinese Medicine Quality Research at the University of Macau.
Both of them are the iconic projects of Guangzhou Pharmaceutical Group to help the moderately diversified economic development of Macao.
By promoting the modernization and industrialization of Chinese medicine, it will accelerate the "Made in Macao" famous products of Guangyao to the world
.
New progress has been made in the cooperation between Guangdong and Macao in Chinese medicine
.
Guangzhou Pharmaceutical International Macau Pharmaceutical Factory is currently the largest and the first Chinese patent medicine pharmaceutical factory designed and constructed in accordance with modern GMP standards in Macau.
Guangyao-University of Australia jointly established a joint laboratory for the transformation of Chinese medicine industry relying on the State Key Laboratory of Traditional Chinese Medicine Quality Research at the University of Macau.
Both of them are the iconic projects of Guangzhou Pharmaceutical Group to help the moderately diversified economic development of Macao.
By promoting the modernization and industrialization of Chinese medicine, it will accelerate the "Made in Macao" famous products of Guangyao to the world
.
It is worth mentioning that at the unveiling ceremony of the "Macao Translational Medicine Innovation Research Institute" held at the University of Macau on the same day, the relevant person in charge of Guangzhou Pharmaceutical Group introduced the phased results of the secondary development of Banlangen and the industrialization project in Macau
.
Baiyunshan Radix is expected to be in Macau medicine one of the first legislative registration of proprietary Chinese medicines
.
.
Baiyunshan Radix is expected to be in Macau medicine one of the first legislative registration of proprietary Chinese medicines
.
Standardized and standardized pharmaceutical factories landed to create "Made in Macau" famous and high-quality products
The Chinese medicine industry is one of the industries that Macau has focused on fostering in order to promote moderately diversified economic development
.
Macau has obvious advantages in the development of the traditional Chinese medicine industry, but there has been a lack of Chinese patent medicine production bases that meet GMP standards
.
.
Macau has obvious advantages in the development of the traditional Chinese medicine industry, but there has been a lack of Chinese patent medicine production bases that meet GMP standards
.
At the beginning of 2020, with the goal of promoting cooperation between Guangdong and Macao, assisting the moderately diversified economic development of Macao, and accelerating the internationalization of Chinese medicine, Guangzhou Pharmaceutical Group established an international headquarters in Macao, and quickly began to prepare a GMP-compliant Chinese patent medicine production base in Macao to help promote The production of Chinese patent medicines in Macau is standardized and standardized
.
.
Guangzhou Pharmaceutical International Macau Pharmaceutical Factory is located in the cross-border industrial zone of Macau Green Island.
The first phase of the project covers an area of 2,341.
82 square meters.
It is equipped with Chinese medicine granules, water honey pills, big honey pills, hard capsules, soft capsules, tablets and liniment.
The preparation production line has obtained qualifications such as the pharmaceutical industry production license issued by the Macau SAR Government.
It is currently the largest and the first Chinese medicine preparation manufacturing demonstration plant in Macau that meets modern GMP standards.
The second phase of the project will gradually lay down production lines for oral liquids, beverages, and emulsions.
, And strive to create a batch of "Made in Macau" fine Chinese patent medicines and big health products
.
The first phase of the project covers an area of 2,341.
82 square meters.
It is equipped with Chinese medicine granules, water honey pills, big honey pills, hard capsules, soft capsules, tablets and liniment.
The preparation production line has obtained qualifications such as the pharmaceutical industry production license issued by the Macau SAR Government.
It is currently the largest and the first Chinese medicine preparation manufacturing demonstration plant in Macau that meets modern GMP standards.
The second phase of the project will gradually lay down production lines for oral liquids, beverages, and emulsions.
, And strive to create a batch of "Made in Macau" fine Chinese patent medicines and big health products
.
It is reported that the first batch of "Made in Macao" famous products of Guangzhou medicine include Baiyunshan Banlangen Granules, Compound Banlangen Granules, Angong Niuhuang Pills, Ganoderma Spore Oil, etc.
The follow-up will continue to introduce Naoxinqing Tablets, Xueshuantong Capsules, and Huoxiang Zhengqi Pills.
, Ertian oil and other proprietary Chinese medicine products
.
Among them, the international version of Ganoderma lucidum spore oil has been launched in Macau, and consumers can mail it to most countries and regions in the world after purchasing it in Macau
.
Relying on policies and location advantages, in the future, famous and high-quality Chinese patent medicines "Made in Macau" are expected to accelerate overseas
.
The follow-up will continue to introduce Naoxinqing Tablets, Xueshuantong Capsules, and Huoxiang Zhengqi Pills.
, Ertian oil and other proprietary Chinese medicine products
.
Among them, the international version of Ganoderma lucidum spore oil has been launched in Macau, and consumers can mail it to most countries and regions in the world after purchasing it in Macau
.
Relying on policies and location advantages, in the future, famous and high-quality Chinese patent medicines "Made in Macau" are expected to accelerate overseas
.
Li Chuyuan, Secretary of the Party Committee and Chairman of Guangzhou Pharmaceutical Group, said that Guangzhou Pharmaceutical International Macau Pharmaceutical Factory is a specific measure of Guangzhou Pharmaceutical Group to promote the modernization and industrialization of high-quality Chinese medicine in Macau
.
Next, Guangzhou Pharmaceutical Group will make full use of the resource advantages of Guangdong and Macao to promote "one product, two sales" and actively explore domestic and foreign markets
.
.
Next, Guangzhou Pharmaceutical Group will make full use of the resource advantages of Guangdong and Macao to promote "one product, two sales" and actively explore domestic and foreign markets
.
Strengthen Cooperation and Innovation to Promote the Industrialization of Banlangen Scientific Research Achievements
Promote the internationalization of the Chinese medicine industry, with innovation first
.
After the establishment of a joint laboratory for the transformation of the Chinese medicine industry by the Guangzhou Pharmaceutical University and the University of Macau, the Guangzhou Pharmaceutical Group will further in-depth cooperation with the University of Macau, relying on the State Key Laboratory of Traditional Chinese Medicine Quality Research at the University of Macau to promote the modernization of Chinese medicine
.
At present, the two parties have cooperated in the comprehensive development and standard establishment of authentic medicinal resources, the re-evaluation and new product development of Chinese patent medicines after the market, the quality and process research of classic famous prescriptions such as Huangqi Guizhi Wuwu Decoction, etc.
, Zishen Yutai Wan, Angong Niuhuang Wan, Xia Sang Ju, Ci Ning Ji series products and other famous and high-quality products have been re-developed
.
.
After the establishment of a joint laboratory for the transformation of the Chinese medicine industry by the Guangzhou Pharmaceutical University and the University of Macau, the Guangzhou Pharmaceutical Group will further in-depth cooperation with the University of Macau, relying on the State Key Laboratory of Traditional Chinese Medicine Quality Research at the University of Macau to promote the modernization of Chinese medicine
.
At present, the two parties have cooperated in the comprehensive development and standard establishment of authentic medicinal resources, the re-evaluation and new product development of Chinese patent medicines after the market, the quality and process research of classic famous prescriptions such as Huangqi Guizhi Wuwu Decoction, etc.
, Zishen Yutai Wan, Angong Niuhuang Wan, Xia Sang Ju, Ci Ning Ji series products and other famous and high-quality products have been re-developed
.
At the unveiling ceremony of the "Macao Institute of Translational Medicine Innovation", Guangzhou Pharmaceutical Group was invited to introduce the industrialization of Baiyunshan Banlangen scientific research results in Macao
.
According to reports, Baiyunshan Banlangen is a large variety of famous Chinese patent medicines of Guangzhou Pharmaceutical Group.
It has the advantages of good scientific research foundation, high product sales, and large brand influence, with a market share of over 60%
.
As early as 2008, Guangzhou Pharmaceutical Group joined hands with Guangzhou Institute of Respiratory Diseases, Macau University of Science and Technology and other units to carry out clinical evidence-based and basic research on Isatis indigotica
.
After setting up its international headquarters in Macau, Guangzhou Pharmaceutical Group actively promoted the industrialization of the latest scientific research results of Baiyunshan Banlangen in Macau
.
.
According to reports, Baiyunshan Banlangen is a large variety of famous Chinese patent medicines of Guangzhou Pharmaceutical Group.
It has the advantages of good scientific research foundation, high product sales, and large brand influence, with a market share of over 60%
.
As early as 2008, Guangzhou Pharmaceutical Group joined hands with Guangzhou Institute of Respiratory Diseases, Macau University of Science and Technology and other units to carry out clinical evidence-based and basic research on Isatis indigotica
.
After setting up its international headquarters in Macau, Guangzhou Pharmaceutical Group actively promoted the industrialization of the latest scientific research results of Baiyunshan Banlangen in Macau
.
At present, the project has entered a substantive implementation stage.
The compound Banlangen granules obtained a pre-license for importing traditional medicines in Macau in January this year and entered the Macau market
.
Next, Guangzhou Pharmaceutical Group will focus on creating two new products-a compound Radix isatidis with the same name and the same prescription and an improved Radix isatidis new medicine, which will be the first to realize the innovation of Baiyunshan Isatis root, made in Macau, and sold in Macau
.
The compound Banlangen granules obtained a pre-license for importing traditional medicines in Macau in January this year and entered the Macau market
.
Next, Guangzhou Pharmaceutical Group will focus on creating two new products-a compound Radix isatidis with the same name and the same prescription and an improved Radix isatidis new medicine, which will be the first to realize the innovation of Baiyunshan Isatis root, made in Macau, and sold in Macau
.
Exploiting the advantages of Guangdong and Macao to promote Chinese medicine sailing to the sea
The Chinese medicine industry is an important area for deepening the cooperation and development between Guangdong and Macao
.
Guangzhou Pharmaceutical Group aims at the two key aspects of modernization and industrialization of Chinese medicine, and leverages the advantages of Guangdong and Macao to develop "Guangdong-Macao innovation + Macau manufacturing"-in addition to strengthening scientific research cooperation with the University of Macau and Macau University of Science and Technology and building Guangyao In addition to the International Macau Pharmaceutical Factory, Guangzhou Pharmaceutical (Zhuhai Hengqin) Pharmaceutical Industrial Park Co.
, Ltd.
has also been established in the Guangdong-Macao Traditional Chinese Medicine Industrial Park, positioning it as a platform for the industrialization of pharmaceutical research and development, and is committed to expanding the development space of the Macau International Headquarters industry.
Projects such as the Zhuhai Hengqin Sub-center of the International Engineering Research Center for Modernization of Traditional Chinese Medicine Extraction and Separation Processes and the Guangzhou Pharmaceutical Zhuhai Hengqin Pharmaceutical Supply Chain are being introduced successively
.
.
Guangzhou Pharmaceutical Group aims at the two key aspects of modernization and industrialization of Chinese medicine, and leverages the advantages of Guangdong and Macao to develop "Guangdong-Macao innovation + Macau manufacturing"-in addition to strengthening scientific research cooperation with the University of Macau and Macau University of Science and Technology and building Guangyao In addition to the International Macau Pharmaceutical Factory, Guangzhou Pharmaceutical (Zhuhai Hengqin) Pharmaceutical Industrial Park Co.
, Ltd.
has also been established in the Guangdong-Macao Traditional Chinese Medicine Industrial Park, positioning it as a platform for the industrialization of pharmaceutical research and development, and is committed to expanding the development space of the Macau International Headquarters industry.
Projects such as the Zhuhai Hengqin Sub-center of the International Engineering Research Center for Modernization of Traditional Chinese Medicine Extraction and Separation Processes and the Guangzhou Pharmaceutical Zhuhai Hengqin Pharmaceutical Supply Chain are being introduced successively
.
In August of this year, the 2021 Fortune Global 500 list was released, and Guangyao Group became the world's first company on the list with traditional Chinese medicine as its main business , ranking 468th and profit ranking 390th
.
"Stepping into the world's top 500 will strengthen our confidence in the international development of traditional Chinese medicine
.
" Li Chuyuan said that in the future, Guangzhou Pharmaceutical Group will focus on modernization in the Macau Qingzhou Cross-border Industrial Zone and Zhuhai Hengqin Guangdong-Macao Traditional Chinese Medicine Industrial Park.
The production and scientific research incubation base of the Chinese medicine industry will promote more Chinese medicine products to the sea
.
.
"Stepping into the world's top 500 will strengthen our confidence in the international development of traditional Chinese medicine
.
" Li Chuyuan said that in the future, Guangzhou Pharmaceutical Group will focus on modernization in the Macau Qingzhou Cross-border Industrial Zone and Zhuhai Hengqin Guangdong-Macao Traditional Chinese Medicine Industrial Park.
The production and scientific research incubation base of the Chinese medicine industry will promote more Chinese medicine products to the sea
.
It is reported that at present, Guangzhou Pharmaceutical Group is making every effort to become a world-class biomedicine and health company with industrial characteristics and distinctive culture, and accelerate the expansion of the international market
.
In the future, it will further introduce and cultivate the whole industry chain business in Macau and Hengqin, including the identification and analysis of traditional Chinese medicine, the production and sales of Chinese medicine decoction pieces, the research and development and manufacturing of Chinese patent medicines, the research and development and manufacturing of large health care products , the commercial circulation of pharmaceutical products, and the characteristic health services of traditional Chinese medicine.
Guangdong-Hong Kong-Macao Greater Bay Area, Southeast Asia, countries and regions along the “Belt and Road” provide a series of proprietary Chinese medicines and well-known and high-quality products to help the moderately diversified economic development of Macau, promote the international development of Chinese medicine, and build a community of human health and health.
"Guangdong Medicine Program"
.
.
In the future, it will further introduce and cultivate the whole industry chain business in Macau and Hengqin, including the identification and analysis of traditional Chinese medicine, the production and sales of Chinese medicine decoction pieces, the research and development and manufacturing of Chinese patent medicines, the research and development and manufacturing of large health care products , the commercial circulation of pharmaceutical products, and the characteristic health services of traditional Chinese medicine.
Guangdong-Hong Kong-Macao Greater Bay Area, Southeast Asia, countries and regions along the “Belt and Road” provide a series of proprietary Chinese medicines and well-known and high-quality products to help the moderately diversified economic development of Macau, promote the international development of Chinese medicine, and build a community of human health and health.
"Guangdong Medicine Program"
.
Recently, Guangzhou Pharmaceutical Group held the completion and commissioning ceremony of the Guangzhou Pharmaceutical International Pharmaceutical Factory in Macau and the unveiling ceremony of the Guangzhou Pharmaceutical-University of Australia Co-construction of the Chinese Medicine Industry Transformation Joint Laboratory in Macau.
New progress has been made in the cooperation between Guangdong and Macao in Chinese medicine
.
Guangzhou Pharmaceutical International Macau Pharmaceutical Factory is currently the largest and the first Chinese patent medicine pharmaceutical factory designed and constructed in accordance with modern GMP standards in Macau.
Guangyao-University of Australia jointly established a joint laboratory for the transformation of Chinese medicine industry relying on the State Key Laboratory of Traditional Chinese Medicine Quality Research at the University of Macau.
Both of them are the iconic projects of Guangzhou Pharmaceutical Group to help the moderately diversified economic development of Macao.
By promoting the modernization and industrialization of Chinese medicine, it will accelerate the "Made in Macao" famous products of Guangyao to the world
.
New progress has been made in the cooperation between Guangdong and Macao in Chinese medicine
.
Guangzhou Pharmaceutical International Macau Pharmaceutical Factory is currently the largest and the first Chinese patent medicine pharmaceutical factory designed and constructed in accordance with modern GMP standards in Macau.
Guangyao-University of Australia jointly established a joint laboratory for the transformation of Chinese medicine industry relying on the State Key Laboratory of Traditional Chinese Medicine Quality Research at the University of Macau.
Both of them are the iconic projects of Guangzhou Pharmaceutical Group to help the moderately diversified economic development of Macao.
By promoting the modernization and industrialization of Chinese medicine, it will accelerate the "Made in Macao" famous products of Guangyao to the world
.
It is worth mentioning that at the unveiling ceremony of the "Macao Translational Medicine Innovation Research Institute" held at the University of Macau on the same day, the relevant person in charge of Guangzhou Pharmaceutical Group introduced the phased results of the secondary development of Banlangen and the industrialization project in Macau
.
Baiyunshan Radix is expected to be in Macau medicine one of the first legislative registration of proprietary Chinese medicines
.
.
Baiyunshan Radix is expected to be in Macau medicine one of the first legislative registration of proprietary Chinese medicines
.
Standardized and standardized pharmaceutical factories landed to create "Made in Macau" famous and high-quality products
The Chinese medicine industry is one of the industries that Macau has focused on fostering in order to promote moderately diversified economic development
.
Macau has obvious advantages in the development of the traditional Chinese medicine industry, but there has been a lack of Chinese patent medicine production bases that meet GMP standards
.
.
Macau has obvious advantages in the development of the traditional Chinese medicine industry, but there has been a lack of Chinese patent medicine production bases that meet GMP standards
.
At the beginning of 2020, with the goal of promoting cooperation between Guangdong and Macao, assisting the moderately diversified economic development of Macao, and accelerating the internationalization of Chinese medicine, Guangzhou Pharmaceutical Group established an international headquarters in Macao, and quickly began to prepare a GMP-compliant Chinese patent medicine production base in Macao to help promote The production of Chinese patent medicines in Macau is standardized and standardized
.
.
Guangzhou Pharmaceutical International Macau Pharmaceutical Factory is located in the cross-border industrial zone of Macau Green Island.
The first phase of the project covers an area of 2,341.
82 square meters.
It is equipped with Chinese medicine granules, water honey pills, big honey pills, hard capsules, soft capsules, tablets and liniment.
The preparation production line has obtained qualifications such as the pharmaceutical industry production license issued by the Macau SAR Government.
It is currently the largest and the first Chinese medicine preparation manufacturing demonstration plant in Macau that meets modern GMP standards.
The second phase of the project will gradually lay down production lines for oral liquids, beverages, and emulsions.
, And strive to create a batch of "Made in Macau" fine Chinese patent medicines and big health products
.
The first phase of the project covers an area of 2,341.
82 square meters.
It is equipped with Chinese medicine granules, water honey pills, big honey pills, hard capsules, soft capsules, tablets and liniment.
The preparation production line has obtained qualifications such as the pharmaceutical industry production license issued by the Macau SAR Government.
It is currently the largest and the first Chinese medicine preparation manufacturing demonstration plant in Macau that meets modern GMP standards.
The second phase of the project will gradually lay down production lines for oral liquids, beverages, and emulsions.
, And strive to create a batch of "Made in Macau" fine Chinese patent medicines and big health products
.
It is reported that the first batch of "Made in Macao" famous products of Guangzhou medicine include Baiyunshan Banlangen Granules, Compound Banlangen Granules, Angong Niuhuang Pills, Ganoderma Spore Oil, etc.
The follow-up will continue to introduce Naoxinqing Tablets, Xueshuantong Capsules, and Huoxiang Zhengqi Pills.
, Ertian oil and other proprietary Chinese medicine products
.
Among them, the international version of Ganoderma lucidum spore oil has been launched in Macau, and consumers can mail it to most countries and regions in the world after purchasing it in Macau
.
Relying on policies and location advantages, in the future, famous and high-quality Chinese patent medicines "Made in Macau" are expected to accelerate overseas
.
The follow-up will continue to introduce Naoxinqing Tablets, Xueshuantong Capsules, and Huoxiang Zhengqi Pills.
, Ertian oil and other proprietary Chinese medicine products
.
Among them, the international version of Ganoderma lucidum spore oil has been launched in Macau, and consumers can mail it to most countries and regions in the world after purchasing it in Macau
.
Relying on policies and location advantages, in the future, famous and high-quality Chinese patent medicines "Made in Macau" are expected to accelerate overseas
.
Li Chuyuan, Secretary of the Party Committee and Chairman of Guangzhou Pharmaceutical Group, said that Guangzhou Pharmaceutical International Macau Pharmaceutical Factory is a specific measure of Guangzhou Pharmaceutical Group to promote the modernization and industrialization of high-quality Chinese medicine in Macau
.
Next, Guangzhou Pharmaceutical Group will make full use of the resource advantages of Guangdong and Macao to promote "one product, two sales" and actively explore domestic and foreign markets
.
.
Next, Guangzhou Pharmaceutical Group will make full use of the resource advantages of Guangdong and Macao to promote "one product, two sales" and actively explore domestic and foreign markets
.
Strengthen Cooperation and Innovation to Promote the Industrialization of Banlangen Scientific Research Achievements
Promote the internationalization of the Chinese medicine industry, with innovation first
.
After the establishment of a joint laboratory for the transformation of the Chinese medicine industry by the Guangzhou Pharmaceutical University and the University of Macau, the Guangzhou Pharmaceutical Group will further in-depth cooperation with the University of Macau, relying on the State Key Laboratory of Traditional Chinese Medicine Quality Research at the University of Macau to promote the modernization of Chinese medicine
.
At present, the two parties have cooperated in the comprehensive development and standard establishment of authentic medicinal resources, the re-evaluation and new product development of Chinese patent medicines after the market, the quality and process research of classic famous prescriptions such as Huangqi Guizhi Wuwu Decoction, etc.
, Zishen Yutai Wan, Angong Niuhuang Wan, Xia Sang Ju, Ci Ning Ji series products and other famous and high-quality products have been re-developed
.
.
After the establishment of a joint laboratory for the transformation of the Chinese medicine industry by the Guangzhou Pharmaceutical University and the University of Macau, the Guangzhou Pharmaceutical Group will further in-depth cooperation with the University of Macau, relying on the State Key Laboratory of Traditional Chinese Medicine Quality Research at the University of Macau to promote the modernization of Chinese medicine
.
At present, the two parties have cooperated in the comprehensive development and standard establishment of authentic medicinal resources, the re-evaluation and new product development of Chinese patent medicines after the market, the quality and process research of classic famous prescriptions such as Huangqi Guizhi Wuwu Decoction, etc.
, Zishen Yutai Wan, Angong Niuhuang Wan, Xia Sang Ju, Ci Ning Ji series products and other famous and high-quality products have been re-developed
.
At the unveiling ceremony of the "Macao Institute of Translational Medicine Innovation", Guangzhou Pharmaceutical Group was invited to introduce the industrialization of Baiyunshan Banlangen scientific research results in Macao
.
According to reports, Baiyunshan Banlangen is a large variety of famous Chinese patent medicines of Guangzhou Pharmaceutical Group.
It has the advantages of good scientific research foundation, high product sales, and large brand influence, with a market share of over 60%
.
As early as 2008, Guangzhou Pharmaceutical Group joined hands with Guangzhou Institute of Respiratory Diseases, Macau University of Science and Technology and other units to carry out clinical evidence-based and basic research on Isatis indigotica
.
After setting up its international headquarters in Macau, Guangzhou Pharmaceutical Group actively promoted the industrialization of the latest scientific research results of Baiyunshan Banlangen in Macau
.
.
According to reports, Baiyunshan Banlangen is a large variety of famous Chinese patent medicines of Guangzhou Pharmaceutical Group.
It has the advantages of good scientific research foundation, high product sales, and large brand influence, with a market share of over 60%
.
As early as 2008, Guangzhou Pharmaceutical Group joined hands with Guangzhou Institute of Respiratory Diseases, Macau University of Science and Technology and other units to carry out clinical evidence-based and basic research on Isatis indigotica
.
After setting up its international headquarters in Macau, Guangzhou Pharmaceutical Group actively promoted the industrialization of the latest scientific research results of Baiyunshan Banlangen in Macau
.
At present, the project has entered a substantive implementation stage.
The compound Banlangen granules obtained a pre-license for importing traditional medicines in Macau in January this year and entered the Macau market
.
Next, Guangzhou Pharmaceutical Group will focus on creating two new products-a compound Radix isatidis with the same name and the same prescription and an improved Radix isatidis new medicine, which will be the first to realize the innovation of Baiyunshan Isatis root, made in Macau, and sold in Macau
.
The compound Banlangen granules obtained a pre-license for importing traditional medicines in Macau in January this year and entered the Macau market
.
Next, Guangzhou Pharmaceutical Group will focus on creating two new products-a compound Radix isatidis with the same name and the same prescription and an improved Radix isatidis new medicine, which will be the first to realize the innovation of Baiyunshan Isatis root, made in Macau, and sold in Macau
.
Exploiting the advantages of Guangdong and Macao to promote Chinese medicine sailing to the sea
The Chinese medicine industry is an important area for deepening the cooperation and development between Guangdong and Macao
.
Guangzhou Pharmaceutical Group aims at the two key aspects of modernization and industrialization of Chinese medicine, and leverages the advantages of Guangdong and Macao to develop "Guangdong-Macao innovation + Macau manufacturing"-in addition to strengthening scientific research cooperation with the University of Macau and Macau University of Science and Technology and building Guangyao In addition to the International Macau Pharmaceutical Factory, Guangzhou Pharmaceutical (Zhuhai Hengqin) Pharmaceutical Industrial Park Co.
, Ltd.
has also been established in the Guangdong-Macao Traditional Chinese Medicine Industrial Park, positioning it as a platform for the industrialization of pharmaceutical research and development, and is committed to expanding the development space of the Macau International Headquarters industry.
Projects such as the Zhuhai Hengqin Sub-center of the International Engineering Research Center for Modernization of Traditional Chinese Medicine Extraction and Separation Processes and the Guangzhou Pharmaceutical Zhuhai Hengqin Pharmaceutical Supply Chain are being introduced successively
.
.
Guangzhou Pharmaceutical Group aims at the two key aspects of modernization and industrialization of Chinese medicine, and leverages the advantages of Guangdong and Macao to develop "Guangdong-Macao innovation + Macau manufacturing"-in addition to strengthening scientific research cooperation with the University of Macau and Macau University of Science and Technology and building Guangyao In addition to the International Macau Pharmaceutical Factory, Guangzhou Pharmaceutical (Zhuhai Hengqin) Pharmaceutical Industrial Park Co.
, Ltd.
has also been established in the Guangdong-Macao Traditional Chinese Medicine Industrial Park, positioning it as a platform for the industrialization of pharmaceutical research and development, and is committed to expanding the development space of the Macau International Headquarters industry.
Projects such as the Zhuhai Hengqin Sub-center of the International Engineering Research Center for Modernization of Traditional Chinese Medicine Extraction and Separation Processes and the Guangzhou Pharmaceutical Zhuhai Hengqin Pharmaceutical Supply Chain are being introduced successively
.
In August of this year, the 2021 Fortune Global 500 list was released, and Guangyao Group became the world's first company on the list with traditional Chinese medicine as its main business , ranking 468th and profit ranking 390th
.
"Stepping into the world's top 500 will strengthen our confidence in the international development of traditional Chinese medicine
.
" Li Chuyuan said that in the future, Guangzhou Pharmaceutical Group will focus on modernization in the Macau Qingzhou Cross-border Industrial Zone and Zhuhai Hengqin Guangdong-Macao Traditional Chinese Medicine Industrial Park.
The production and scientific research incubation base of the Chinese medicine industry will promote more Chinese medicine products to the sea
.
.
"Stepping into the world's top 500 will strengthen our confidence in the international development of traditional Chinese medicine
.
" Li Chuyuan said that in the future, Guangzhou Pharmaceutical Group will focus on modernization in the Macau Qingzhou Cross-border Industrial Zone and Zhuhai Hengqin Guangdong-Macao Traditional Chinese Medicine Industrial Park.
The production and scientific research incubation base of the Chinese medicine industry will promote more Chinese medicine products to the sea
.
It is reported that at present, Guangzhou Pharmaceutical Group is making every effort to become a world-class biomedicine and health company with industrial characteristics and distinctive culture, and accelerate the expansion of the international market
.
In the future, it will further introduce and cultivate the whole industry chain business in Macau and Hengqin, including the identification and analysis of traditional Chinese medicine, the production and sales of Chinese medicine decoction pieces, the research and development and manufacturing of Chinese patent medicines, the research and development and manufacturing of large health care products , the commercial circulation of pharmaceutical products, and the characteristic health services of traditional Chinese medicine.
Guangdong-Hong Kong-Macao Greater Bay Area, Southeast Asia, countries and regions along the “Belt and Road” provide a series of proprietary Chinese medicines and well-known and high-quality products to help the moderately diversified economic development of Macau, promote the international development of Chinese medicine, and build a community of human health and health.
"Guangdong Medicine Program"
.
.
In the future, it will further introduce and cultivate the whole industry chain business in Macau and Hengqin, including the identification and analysis of traditional Chinese medicine, the production and sales of Chinese medicine decoction pieces, the research and development and manufacturing of Chinese patent medicines, the research and development and manufacturing of large health care products , the commercial circulation of pharmaceutical products, and the characteristic health services of traditional Chinese medicine.
Guangdong-Hong Kong-Macao Greater Bay Area, Southeast Asia, countries and regions along the “Belt and Road” provide a series of proprietary Chinese medicines and well-known and high-quality products to help the moderately diversified economic development of Macau, promote the international development of Chinese medicine, and build a community of human health and health.
"Guangdong Medicine Program"
.
Recently, Guangzhou Pharmaceutical Group held the completion and commissioning ceremony of the Guangzhou Pharmaceutical International Pharmaceutical Factory in Macau and the unveiling ceremony of the Guangzhou Pharmaceutical-University of Australia Co-construction of the Chinese Medicine Industry Transformation Joint Laboratory in Macau.
New progress has been made in the cooperation between Guangdong and Macao in Chinese medicine
.
Guangzhou Pharmaceutical International Macau Pharmaceutical Factory is currently the largest and the first Chinese patent medicine pharmaceutical factory designed and constructed in accordance with modern GMP standards in Macau.
Guangyao-University of Australia jointly established a joint laboratory for the transformation of Chinese medicine industry relying on the State Key Laboratory of Traditional Chinese Medicine Quality Research at the University of Macau.
Both of them are the iconic projects of Guangzhou Pharmaceutical Group to help the moderately diversified economic development of Macao.
By promoting the modernization and industrialization of Chinese medicine, it will accelerate the "Made in Macao" famous products of Guangyao to the world
.
New progress has been made in the cooperation between Guangdong and Macao in Chinese medicine
.
Guangzhou Pharmaceutical International Macau Pharmaceutical Factory is currently the largest and the first Chinese patent medicine pharmaceutical factory designed and constructed in accordance with modern GMP standards in Macau.
Guangyao-University of Australia jointly established a joint laboratory for the transformation of Chinese medicine industry relying on the State Key Laboratory of Traditional Chinese Medicine Quality Research at the University of Macau.
Both of them are the iconic projects of Guangzhou Pharmaceutical Group to help the moderately diversified economic development of Macao.
By promoting the modernization and industrialization of Chinese medicine, it will accelerate the "Made in Macao" famous products of Guangyao to the world
.
It is worth mentioning that at the unveiling ceremony of the "Macao Translational Medicine Innovation Research Institute" held at the University of Macau on the same day, the relevant person in charge of Guangzhou Pharmaceutical Group introduced the phased results of the secondary development of Banlangen and the industrialization project in Macau
.
Baiyunshan Radix is expected to be in Macau medicine one of the first legislative registration of proprietary Chinese medicines
.
Medicine Medicine Medicine.
Baiyunshan Radix is expected to be in Macau medicine one of the first legislative registration of proprietary Chinese medicines
.
Standardized and standardized pharmaceutical factories landed to create "Made in Macau" famous and high-quality products
Standardized and standardized pharmaceutical factories landed to create "Made in Macau" famous and high-quality products The Chinese medicine industry is one of the industries that Macau has focused on fostering in order to promote moderately diversified economic development
.
Macau has obvious advantages in the development of the traditional Chinese medicine industry, but there has been a lack of Chinese patent medicine production bases that meet GMP standards
.
.
Macau has obvious advantages in the development of the traditional Chinese medicine industry, but there has been a lack of Chinese patent medicine production bases that meet GMP standards
.
At the beginning of 2020, with the goal of promoting cooperation between Guangdong and Macao, assisting the moderately diversified economic development of Macao, and accelerating the internationalization of Chinese medicine, Guangzhou Pharmaceutical Group established an international headquarters in Macao, and quickly began to prepare a GMP-compliant Chinese patent medicine production base in Macao to help promote The production of Chinese patent medicines in Macau is standardized and standardized
.
.
Guangzhou Pharmaceutical International Macau Pharmaceutical Factory is located in the cross-border industrial zone of Macau Green Island.
The first phase of the project covers an area of 2,341.
82 square meters.
It is equipped with Chinese medicine granules, water honey pills, big honey pills, hard capsules, soft capsules, tablets and liniment.
The preparation production line has obtained qualifications such as the pharmaceutical industry production license issued by the Macau SAR Government.
It is currently the largest and the first Chinese medicine preparation manufacturing demonstration plant in Macau that meets modern GMP standards.
The second phase of the project will gradually lay down production lines for oral liquids, beverages, and emulsions.
, And strive to create a batch of "Made in Macau" fine Chinese patent medicines and big health products
.
The first phase of the project covers an area of 2,341.
82 square meters.
It is equipped with Chinese medicine granules, water honey pills, big honey pills, hard capsules, soft capsules, tablets and liniment.
The preparation production line has obtained qualifications such as the pharmaceutical industry production license issued by the Macau SAR Government.
It is currently the largest and the first Chinese medicine preparation manufacturing demonstration plant in Macau that meets modern GMP standards.
The second phase of the project will gradually lay down production lines for oral liquids, beverages, and emulsions.
, And strive to create a batch of "Made in Macau" fine Chinese patent medicines and big health products
.
It is reported that the first batch of "Made in Macao" famous products of Guangzhou medicine include Baiyunshan Banlangen Granules, Compound Banlangen Granules, Angong Niuhuang Pills, Ganoderma Spore Oil, etc.
The follow-up will continue to introduce Naoxinqing Tablets, Xueshuantong Capsules, and Huoxiang Zhengqi Pills.
, Ertian oil and other proprietary Chinese medicine products
.
Among them, the international version of Ganoderma lucidum spore oil has been launched in Macau, and consumers can mail it to most countries and regions in the world after purchasing it in Macau
.
Relying on policies and location advantages, in the future, famous and high-quality Chinese patent medicines "Made in Macau" are expected to accelerate overseas
.
The follow-up will continue to introduce Naoxinqing Tablets, Xueshuantong Capsules, and Huoxiang Zhengqi Pills.
, Ertian oil and other proprietary Chinese medicine products
.
Among them, the international version of Ganoderma lucidum spore oil has been launched in Macau, and consumers can mail it to most countries and regions in the world after purchasing it in Macau
.
Relying on policies and location advantages, in the future, famous and high-quality Chinese patent medicines "Made in Macau" are expected to accelerate overseas
.
Li Chuyuan, Secretary of the Party Committee and Chairman of Guangzhou Pharmaceutical Group, said that Guangzhou Pharmaceutical International Macau Pharmaceutical Factory is a specific measure of Guangzhou Pharmaceutical Group to promote the modernization and industrialization of high-quality Chinese medicine in Macau
.
Next, Guangzhou Pharmaceutical Group will make full use of the resource advantages of Guangdong and Macao to promote "one product, two sales" and actively explore domestic and foreign markets
.
.
Next, Guangzhou Pharmaceutical Group will make full use of the resource advantages of Guangdong and Macao to promote "one product, two sales" and actively explore domestic and foreign markets
.
Strengthen Cooperation and Innovation to Promote the Industrialization of Banlangen Scientific Research Achievements
Strengthen Cooperation and Innovation to Promote the Industrialization of Banlangen Scientific Research Achievements Promote the internationalization of the Chinese medicine industry, with innovation first
.
After the establishment of a joint laboratory for the transformation of the Chinese medicine industry by the Guangzhou Pharmaceutical University and the University of Macau, the Guangzhou Pharmaceutical Group will further in-depth cooperation with the University of Macau, relying on the State Key Laboratory of Traditional Chinese Medicine Quality Research at the University of Macau to promote the modernization of Chinese medicine
.
At present, the two parties have cooperated in the comprehensive development and standard establishment of authentic medicinal resources, the re-evaluation and new product development of Chinese patent medicines after the market, the quality and process research of classic famous prescriptions such as Huangqi Guizhi Wuwu Decoction, etc.
, Zishen Yutai Wan, Angong Niuhuang Wan, Xia Sang Ju, Ci Ning Ji series products and other famous and high-quality products have been re-developed
.
Herbs medicinal herbs.
After the establishment of a joint laboratory for the transformation of the Chinese medicine industry by the Guangzhou Pharmaceutical University and the University of Macau, the Guangzhou Pharmaceutical Group will further in-depth cooperation with the University of Macau, relying on the State Key Laboratory of Traditional Chinese Medicine Quality Research at the University of Macau to promote the modernization of Chinese medicine
.
At present, the two parties have cooperated in the comprehensive development and standard establishment of authentic medicinal resources, the re-evaluation and new product development of Chinese patent medicines after the market, the quality and process research of classic famous prescriptions such as Huangqi Guizhi Wuwu Decoction, etc.
, Zishen Yutai Wan, Angong Niuhuang Wan, Xia Sang Ju, Ci Ning Ji series products and other famous and high-quality products have been re-developed
.
At the unveiling ceremony of the "Macao Institute of Translational Medicine Innovation", Guangzhou Pharmaceutical Group was invited to introduce the industrialization of Baiyunshan Banlangen scientific research results in Macao
.
According to reports, Baiyunshan Banlangen is a large variety of famous Chinese patent medicines of Guangzhou Pharmaceutical Group.
It has the advantages of good scientific research foundation, high product sales, and large brand influence, with a market share of over 60%
.
As early as 2008, Guangzhou Pharmaceutical Group joined hands with Guangzhou Institute of Respiratory Diseases, Macau University of Science and Technology and other units to carry out clinical evidence-based and basic research on Isatis indigotica
.
After setting up its international headquarters in Macau, Guangzhou Pharmaceutical Group actively promoted the industrialization of the latest scientific research results of Baiyunshan Banlangen in Macau
.
.
According to reports, Baiyunshan Banlangen is a large variety of famous Chinese patent medicines of Guangzhou Pharmaceutical Group.
It has the advantages of good scientific research foundation, high product sales, and large brand influence, with a market share of over 60%
.
As early as 2008, Guangzhou Pharmaceutical Group joined hands with Guangzhou Institute of Respiratory Diseases, Macau University of Science and Technology and other units to carry out clinical evidence-based and basic research on Isatis indigotica
.
After setting up its international headquarters in Macau, Guangzhou Pharmaceutical Group actively promoted the industrialization of the latest scientific research results of Baiyunshan Banlangen in Macau
.
At present, the project has entered a substantive implementation stage.
The compound Banlangen granules obtained a pre-license for importing traditional medicines in Macau in January this year and entered the Macau market
.
Next, Guangzhou Pharmaceutical Group will focus on creating two new products-a compound Radix isatidis with the same name and the same prescription and an improved Radix isatidis new medicine, which will be the first to realize the innovation of Baiyunshan Isatis root, made in Macau, and sold in Macau
.
The compound Banlangen granules obtained a pre-license for importing traditional medicines in Macau in January this year and entered the Macau market
.
Next, Guangzhou Pharmaceutical Group will focus on creating two new products-a compound Radix isatidis with the same name and the same prescription and an improved Radix isatidis new medicine, which will be the first to realize the innovation of Baiyunshan Isatis root, made in Macau, and sold in Macau
.
Exploiting the advantages of Guangdong and Macao to promote Chinese medicine sailing to the sea
Exploiting the advantages of Guangdong and Macao to promote Chinese medicine sailing to the sea The Chinese medicine industry is an important area for deepening the cooperation and development between Guangdong and Macao
.
Guangzhou Pharmaceutical Group aims at the two key aspects of modernization and industrialization of Chinese medicine, and leverages the advantages of Guangdong and Macao to develop "Guangdong-Macao innovation + Macau manufacturing"-in addition to strengthening scientific research cooperation with the University of Macau and Macau University of Science and Technology and building Guangyao In addition to the International Macau Pharmaceutical Factory, Guangzhou Pharmaceutical (Zhuhai Hengqin) Pharmaceutical Industrial Park Co.
, Ltd.
has also been established in the Guangdong-Macao Traditional Chinese Medicine Industrial Park, positioning it as a platform for the industrialization of pharmaceutical research and development, and is committed to expanding the development space of the Macau International Headquarters industry.
Projects such as the Zhuhai Hengqin Sub-center of the International Engineering Research Center for Modernization of Traditional Chinese Medicine Extraction and Separation Processes and the Guangzhou Pharmaceutical Zhuhai Hengqin Pharmaceutical Supply Chain are being introduced successively
.
.
Guangzhou Pharmaceutical Group aims at the two key aspects of modernization and industrialization of Chinese medicine, and leverages the advantages of Guangdong and Macao to develop "Guangdong-Macao innovation + Macau manufacturing"-in addition to strengthening scientific research cooperation with the University of Macau and Macau University of Science and Technology and building Guangyao In addition to the International Macau Pharmaceutical Factory, Guangzhou Pharmaceutical (Zhuhai Hengqin) Pharmaceutical Industrial Park Co.
, Ltd.
has also been established in the Guangdong-Macao Traditional Chinese Medicine Industrial Park, positioning it as a platform for the industrialization of pharmaceutical research and development, and is committed to expanding the development space of the Macau International Headquarters industry.
Projects such as the Zhuhai Hengqin Sub-center of the International Engineering Research Center for Modernization of Traditional Chinese Medicine Extraction and Separation Processes and the Guangzhou Pharmaceutical Zhuhai Hengqin Pharmaceutical Supply Chain are being introduced successively
.
In August of this year, the 2021 Fortune Global 500 list was released, and Guangyao Group became the world's first company on the list with traditional Chinese medicine as its main business , ranking 468th and profit ranking 390th
.
"Stepping into the world's top 500 will strengthen our confidence in the international development of traditional Chinese medicine
.
" Li Chuyuan said that in the future, Guangzhou Pharmaceutical Group will focus on modernization in the Macau Qingzhou Cross-border Industrial Zone and Zhuhai Hengqin Guangdong-Macao Traditional Chinese Medicine Industrial Park.
The production and scientific research incubation base of the Chinese medicine industry will promote more Chinese medicine products to the sea
.
Enterprise Enterprise Enterprise Chinese Medicine Chinese Medicine Chinese Medicine.
"Stepping into the world's top 500 will strengthen our confidence in the international development of traditional Chinese medicine
.
" Li Chuyuan said that in the future, Guangzhou Pharmaceutical Group will focus on modernization in the Macau Qingzhou Cross-border Industrial Zone and Zhuhai Hengqin Guangdong-Macao Traditional Chinese Medicine Industrial Park.
The production and scientific research incubation base of the Chinese medicine industry will promote more Chinese medicine products to the sea
.
It is reported that at present, Guangzhou Pharmaceutical Group is making every effort to become a world-class biomedicine and health company with industrial characteristics and distinctive culture, and accelerate the expansion of the international market
.
In the future, it will further introduce and cultivate the whole industry chain business in Macau and Hengqin, including the identification and analysis of traditional Chinese medicine, the production and sales of Chinese medicine decoction pieces, the research and development and manufacturing of Chinese patent medicines, the research and development and manufacturing of large health care products , the commercial circulation of pharmaceutical products, and the characteristic health services of traditional Chinese medicine.
Guangdong-Hong Kong-Macao Greater Bay Area, Southeast Asia, countries and regions along the “Belt and Road” provide a series of proprietary Chinese medicines and well-known and high-quality products to help the moderately diversified economic development of Macau, promote the international development of Chinese medicine, and build a community of human health and health.
"Guangdong Medicine Program"
.
Health care products health products .
In the future, it will further introduce and cultivate the whole industry chain business in Macau and Hengqin, including the identification and analysis of traditional Chinese medicine, the production and sales of Chinese medicine decoction pieces, the research and development and manufacturing of Chinese patent medicines, the research and development and manufacturing of large health care products , the commercial circulation of pharmaceutical products, and the characteristic health services of traditional Chinese medicine.
Guangdong-Hong Kong-Macao Greater Bay Area, Southeast Asia, countries and regions along the “Belt and Road” provide a series of proprietary Chinese medicines and well-known and high-quality products to help the moderately diversified economic development of Macau, promote the international development of Chinese medicine, and build a community of human health and health.
"Guangdong Medicine Program"
.
